Uncovering the trimethylamine-producing bacteria of the human gut microbiota
Open accessAbstract
BACKGROUND: Trimethylamine (TMA), produced by the gut microbiota from dietary quaternary amines (mainly choline and carnitine), is associated with atherosclerosis and severe cardiovascular disease. Currently, little information on the composition of TMA producers in the gut is available due to their low abundance and the requirement of specific functional-based detection methods as many taxa show disparate abilities to produce that compound. RESULTS: In order to examine the TMA-forming potential of microbial communities, we established databases for the key genes of the main TMA-synthesis pathways, encoding choline TMA-lyase (cutC) and carnitine oxygenase (cntA), using a multi-level screening approach on 67,134 genomes revealing 1107 and 6738 candidates to exhibit cutC and cntA, respectively. Gene-targeted assays enumerating the TMA-producing community by quantitative PCR and characterizing its composition via Illumina sequencing were developed and applied on human fecal samples (n = 50) where all samples contained potential TMA producers (cutC was detected in all individuals, whereas only 26% harbored cntA) constituting, however, only a minor part of the total community (below 1% in most samples). Obtained cutC amplicons were associated with various taxa, in particular with Clostridium XIVa strains and Eubacterium sp. strain AB3007, though a bulk of sequences displayed low nucleotide identities to references (average 86% ± 7%) indicating that key human TMA producers are yet to be isolated. Co-occurrence analysis revealed specific groups governing the community structure of cutC-exhibiting taxa across samples. CntA amplicons displayed high identities (~99%) to Gammaproteobacteria-derived references, primarily from Escherichia coli. Metagenomic analysis of samples provided by the Human Microbiome Project (n = 154) confirmed the abundance patterns as well as overall taxonomic compositions obtained with our assays, though at much lower resolution, whereas 16S ribosomal RNA gene sequence analysis could not adequately uncover the TMA-producing potential. CONCLUSIONS: In this study, we developed a diagnostic framework that enabled the quantification and comprehensive characterization of the TMA-producing potential in human fecal samples. The key players were identified, and together with predictions on their environmental niches using functional genomics on most closely related reference strains, we provide crucial information for the development of specific treatment strategies to restrain TMA producers and limit their proliferation.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper builds databases and gene-targeted qPCR/sequencing assays for the gut microbial trimethylamine (TMA)-synthesis genes cutC and cntA, then applies them to human fecal samples. It finds that potential TMA producers are common but low-abundance, with cutC dominated by diverse Clostridium XIVa-related sequences and cntA mostly Escherichia coli-like Gammaproteobacteria.
Key findings
- Screening 67,134 PATRIC genomes yielded final databases of 1114 cutC candidate genes (454 unique proteins) and 6772 cntA candidate genes (491 unique proteins); the abstract reports 1107 cutC and 6738 cntA candidates.
- In 50 human fecal samples, cutC was detected in all individuals at an average of 0.16% ± 0.15% of total bacteria, while cntA was quantified in 13 samples (26%) at 0.03–2.17%, with only three samples ≥0.5%.
- cutC amplicons were diverse and often only distantly related to references (average 86% ± 7% nucleotide identity), mainly resembling Clostridium XIVa strains and Eubacterium sp. strain AB3007; cntA amplicons were highly similar to references (99.5% ± 0.5%), primarily Escherichia coli/Gammaproteobacteria.
- In 154 Human Microbiome Project metagenomes, 71% harbored cutC/D at an average 0.11% of bacteria and 27% were positive for cntA/B; 16S rRNA gene analysis did not adequately uncover TMA-producing potential.
Methods
- Databases for cutC and cntA were built using a multi-level HMM screening approach on 67,134 PATRIC genomes, incorporating conserved amino acid sites, phylogenetic distance, and synteny with cutD or cntB.
- Gene-targeted qPCR and Illumina MiSeq amplicon sequencing assays were developed and applied to 50 human fecal samples, with primer coverage estimated at 93% of unique cutC genes and 96% of unique cntA genes; quantification limit was 5 × 10³ genome copies per reaction.
- Analyses included 16S rRNA gene profiling, metagenomic screening of 154 HMP samples and reanalysis of 12 atherosclerosis patients versus 13 controls, co-occurrence/ordination of cutC communities, and functional genomic comparisons of Clostridium XIVa strains.
Limitations
- The paper states that only TMA-producing potential was measured, not gene expression or actual TMA production; volunteer metadata varied substantially and hindered identification of specific host factors governing the community.
- The paper states that metagenomic depth was insufficient for assembly of low-abundance targets, and the atherosclerosis reanalysis had low sample size and non-significant differences despite about twofold higher median cutC/cntA abundances in patients.
- The paper notes primer coverage gaps (some Betaproteobacteria for cntA; some Streptococcus for cutC) and unspecific cntA amplification requiring per-sample quality control; evident from the text, the study is cross-sectional and does not directly link gene abundance to TMA/TMAO serum concentrations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 31 cited sources checked · 0 supported · 0 flagged
- Findingown data
A separation between samples containing either cluster a or b was detected.
“In particular, a separation between samples containing either cluster a or b was detected.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
Gene-abundance results did not significantly correlate with any subject parameters presented in Additional file 5.
“Gene-abundance results did not significantly correlate with any subject parameters presented in Additional file 5.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
The database developed in this study unequivocally shows that the vast amount of genomes exhibits a single copy of the cntA/yeaW gene group.
“Importantly, a recent report based on a genome-screening approach suggesting that numerous taxa contain both cntA/B and yeaW/X is misleading [11] as the database developed in this study unequivocally shows that the vast amount of genomes exhibits a single copy of this gene group.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Falony G, Vieira-Silva S, Raes J. Microbiology meets big data: the case of gut microbiota-derived trimethylamine. Annu Rev Microbiol. 2015;69:305–21. source
Not checked in the free run.
- Findingown data
The majority of reads indicating the presence of cutC/D were similar to genes of Clostridium XIVa or Eubacterium sp. strain AB3007.
“As shown by amplicon sequencing, the majority of reads indicating the presence of cutC/D were similar to genes of Clostridium XIVa or Eubacterium sp. strain AB3007.”
Quote in the paperSubstantial claim - Findingown data
Target genes were detected in all samples.
“Target genes were detected in all samples”
Quote in the paperSubstantial claim
- Findingown data
All cntA sequences, with one exception, display a conserved bridging glutamate instead of aspartate (E205D), previously suggested as a signature for that enzyme.
“All sequences (with one exception) display a conserved “bridging” glutamate instead of aspartate (E205D), which was previously suggested as a signature for that enzyme [7].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111:4268–73. source
Not checked in the free run.
- Findingown data
High clustering identity cutoffs of 99 and 98% nucleotide similarity revealed high diversities of the cutC gene with several thousand distinct sequence types shared between a few samples, less than 10%.
“Detailed analysis applying high clustering identity cutoffs (99 and 98% nucleotide similarity) revealed high diversities of the cutC gene with several thousand distinct sequence types that are shared between a few samples (<10%; Additional file 6A).”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
Competition patterns between related taxa were detected, in particular between clusters a and b where either taxon dominated in specific samples.
“Although we detected competition patterns between related taxa, in particular between clusters a and b where either taxon dominated in specific samples (Fig. 2)”
Quote in the paperNot a substantial claim - Findingown data
Co-occurrence analysis of cutC amplicons revealed several distinct network groups that were largely directed by the phylogenetic relatedness of clusters.
“Co-occurrence analysis of cutC amplicons based on the clustering results presented in Fig. 2b revealed several distinct network groups that were largely directed by the phylogenetic relatedness of clusters (Fig. 3a).”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
A few communities additionally contained cntA amplicons similar to those previously detected in Citrobacter and Klebsiella.
“A few communities additionally contained cntA amplicons similar to those previously detected in Citrobacter and Klebsiella.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
Sequences associated with three distinct phyla were detected.
“Sequences associated with three distinct phyla were detected”
Quote in the paperSubstantial claim - Findingown data
Co-occurrence of various phylogenetically close TMA-producing genes was observed in most samples.
“co-occurrence of various phylogenetically close TMA-producing genes was observed in most samples”
Quote in the paperNot a substantial claim - Findingown data
Clostridium XIVa and Desulfovibrio relative abundances based on 16S rRNA gene sequence analysis were dissimilar to cutC gene abundances obtained with the assay.
“Specifically, Clostridium XIVa and Desulfovibrio relative abundances based on 16S rRNA gene sequence analysis were dissimilar to cutC gene abundances obtained with our assay.”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
A clear drop in HMM similarity score after sequence 453 co-occurred with abrupt changes in other parameters including phylogenetic distance, depicting a profound change in gene sequences below that drop.
“A clear drop in the HMM similarity score was detected after sequence 453 that co-occurred with abrupt changes in other parameters investigated including phylogenetic distance to the top-scoring sequence depicting a profound change in gene sequences below that drop.”
Quote in the paperSubstantial claim - Findingown data
The majority of detected sequences were associated with those observed in members of the Clostridium XIVa (and a specific Eubacterium).
“but the majority were associated with those observed in members of the Clostridium XIVa (and a specific Eubacterium)”
Quote in the paperSubstantial claim - Findingown data
In the HMP dataset, 25% of samples were negative for cutC/D and cntA/B genes.
“In the HMP dataset, 25% of samples were negative for cutC/D and cntA/B genes”
Quote in the paperNot a substantial claim - Findingown data
Phylogenetic analyses based on 16S rRNA gene sequence similarities demonstrated CutC-encoding Clostridium XIVa strains as a polyphyletic group spanning the entire genus, intermitted by strains lacking that gene.
“Phylogenetic analyses based on 16S rRNA gene sequence similarities demonstrated CutC-encoding Clostridium XIVa strains as a polyphyletic group spanning the entire genus intermitted by strains lacking that gene (Additional file 9A).”
Quote in the paperSubstantial claim - Findingown data
Eubacterium was only detected at very low relative abundances in a few samples.
“Eubacterium was only detected at very low relative abundances in a few samples.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
Our analyses identified distinct groups of TMA-producing gene pools that are each dominated by a few sequence types.
“Our analyses identified distinct groups of TMA-producing gene pools that are each dominated by a few sequence types”
Quote in the paperSubstantial claim - Findingown data
These four assembled sequences were nearly identical, >99%, to sequences previously observed in Clostridium sp. AT5, a Clostridium XIVa strain.
“These sequences were nearly identical (>99%) to those previously observed in Clostridium sp. AT5, a Clostridium XIVa strain.”
Quote in the paperSubstantial claim - Findingown data
IMG phenotype analysis suggested that strains are auxotrophic for several amino acids, on average 11 ± 2.
“The former analysis suggested that strains are auxotrophic for several amino acids (on average, 11 ± 2; Additional file 10B).”
Quote in the paperNot a substantial claim - Findingown data
The observed differences in TMA producer abundances between atherosclerosis patients and controls were statistically not significant.
“However, these observed differences were statistically not significant.”
Quote in the paperNot a substantial claim - Findingown data
Clusters closely associated with Clostridium XIVa strains form separate groups.
“Clusters closely associated with Clostridium XIVa strains form separate groups.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
High diversities of possible TMA producers were observed in fecal samples, in particular of cutC gene sequences.
“The high diversities of possible TMA producers observed in fecal samples, in particular of cutC gene sequences”
Quote in the paperSubstantial claim - Findingown data
CutC genes similar to those previously observed in Actinobacteria, Firmicutes, and Proteobacteria were detected.
“CutC genes similar to those previously observed in all three phyla presented in the database, namely Actinobacteria, Firmicutes, and Proteobacteria, were detected.”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
No significant correlations between cutC gene abundances and relative abundances of respective taxa previously described to contain those genes were observed.
“No significant correlations between gene abundances of cutC with relative abundances of respective taxa previously described to contain those genes were observed (Additional file 7).”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingcitation
Clostridium XIVa strains are characterized by overproportional rich carbohydrate-active enzyme (CAZyme) repertoires within the Lachnospiraceae.
“our analyses indicated that Clostridium XIVa strains are characterized by overproportional rich carbohydrate-active enzyme (CAZyme) repertoires within the Lachnospiraceae [13]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Cantarel BL, Lombard V, Henrissat B. Complex carbohydrate utilization by the healthy human microbiome. PLoS One. 2012;7:e28742. source
Not checked in the free run.
- Findingown data
The bulk of obtained cutC sequences was distantly related to known references of this genus.
“the bulk of obtained cutC sequences was distantly related to known references of this genus”
Quote in the paperSubstantial claim - Findingown data
Observed network patterns were largely reflected in ordination analysis, where samples that grouped together were enriched in specific sequence clusters as expected from co-occurrence analysis.
“The observed network patterns were largely reflected in ordination analysis where samples that grouped together in the ordination plot were enriched in specific sequence clusters as expected from co-occurrence analysis (Fig. 3b).”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
Global feature analysis based on FIGfams suggested large functional differences between members of Clostridium XIVa.
“Global feature analysis based on FIGfams suggested large functional differences between members of Clostridium XIVa”
Quote in the paperNot a substantial claim - Findingown data
All strains are predicted to exhibit CAZymes linked to the break-down of various diet and host-derived substrates.
“All strains are predicted to exhibit CAZymes linked to the break-down of various diet and host-derived substrates (panel C in Additional file 10).”
Quote in the paperNot a substantial claim - Findingown data
In most cntA-positive samples based on qPCR, Escherichia/Shigella and Enterobacteriaceae were detected by 16S rRNA gene sequence analysis.
“Conversely, in most cntA-positive samples (based on qPCR), Escherichia/Shigella and Enterobacteriaceae were detected by 16S rRNA gene sequence analysis.”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
- Findingown data
Two samples derived from the HMP dataset display exceptionally high amounts of cntA, but only minute cutC abundances.
“two samples derived from the HMP dataset that display exceptionally high amounts of cntA, but only minute cutC abundances (Fig. 4)”
Quote in the paperSubstantial claim - Findingown data
All subjects contained target genes.
“All subjects contained target genes”
Quote in the paperSubstantial claim - Findingown data
A multitude of potential TMA-producing taxa were revealed in most samples.
“a multitude of potential TMA-producing taxa were revealed in most samples”
Quote in the paperSubstantial claim - Findingown data
The potential TMA-producing taxa overall clustered into distinct types characterized by highly abundant key players.
“overall, clustered into distinct types characterized by highly abundant key players”
Quote in the paperSubstantial claim - Findingcitation
Reanalysis of the dataset provided by Karlsson and colleagues indicated elevated abundances of potential TMA producers in atherosclerosis patients.
“Reanalysis of the dataset provided by Karlsson and colleagues [12] indicated elevated abundances of potential TMA producers in atherosclerosis patients”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245. source
Not checked in the free run.
- Findingown data
Results of the two pathways (cutC and cntA) did not correlate.
“results of the two pathways did not correlate”
Quote in the paperSubstantial claim - Premisecitation
Only one study estimates the overall potential of intestinal communities to produce TMA.
“So far, only one study estimates the overall potential of intestinal communities to produce TMA [11], and specific structural insights into this functional community are largely lacking.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Falony G, Vieira-Silva S, Raes J. Microbiology meets big data: the case of gut microbiota-derived trimethylamine. Annu Rev Microbiol. 2015;69:305–21. source
Not checked in the free run.
- Premisecitation
Even minute concentrations of TMA producers, 0.15% of the total community, are sufficient for substantial TMA production from choline.
“where even minute concentrations of TMA producers (0.15% of the total community) were sufficient for substantial TMA production from choline.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability. MBio. 2015;6:e02481–14. source
Not checked in the free run.
- Premisecitation
Phylogenetic markers are expected to be poor predictors for TMA production function, at least for the broadly polyphyletic bacteria exhibiting cutC/D.
“as phylogenetic markers are expected to be poor predictors for that function, at least for the broadly polyphyletic bacteria exhibiting cutC/D [9].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Campo AM, Bodea S, Hamer H. Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria. MBio. 2015;6:e00042–15.
Not checked in the free run.
- Premisecitation
Both cutC and cutD are required for the TMA-generating cleavage reaction from choline.
“The authors biochemically verified TMA synthesis from choline for a multitude of the revealed taxa and demonstrated that both cutC and cutD are required for the TMA-generating cleavage reaction.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [9] Campo AM, Bodea S, Hamer H. Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria. MBio. 2015;6:e00042–15.
Not checked in the free run.
- Premisecitation
TMA produced by gut microbiota from dietary quaternary amines, mainly choline and carnitine, is associated with atherosclerosis and severe cardiovascular disease.
“This is exemplified by trimethylamine (TMA), a microbial metabolite that is produced by various taxa of the gut microbiota from dietary quaternary amines, mainly choline and carnitine. TMA is absorbed via the intestinal epithelium and further oxidized to trimethylamine N-oxide (TMAO), which was associated with atherosclerosis and severe cardiovascular disease in several independent studies [1–4].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [1] Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63. source
Not checked in the free run.
- cites [2] Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:1575–84. source
Not checked in the free run.
- cites [3] Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J Intern Med. 2015;277:717–26. source
Not checked in the free run.
- cites [4] Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, et al. Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden. J Am Soc Nephrol. 2015;27:305–13. source
Not checked in the free run.
- Premisecitation
Little information on the abundance and taxonomic composition of TMA-producing bacteria in vivo is available.
“Despite this multitude of knowledge on TMA-producing bacteria and their importance for human health, little information on their abundance and taxonomic composition in vivo is available.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Falony G, Vieira-Silva S, Raes J. Microbiology meets big data: the case of gut microbiota-derived trimethylamine. Annu Rev Microbiol. 2015;69:305–21. source
Not checked in the free run.
- Premisereasoning
In this study, YeaW was considered as belonging to the CntA cluster of enzymes as originally proposed by Zhu and colleagues.
“In this study, we, hence, considered YeaW as belonging to the CntA cluster of enzymes as originally proposed by Zhu and colleagues [7].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111:4268–73. source
Not checked in the free run.
- Interpretationreasoning
Host-derived mucin might serve as a major nutrient source for Clostridium XIVa strains.
“where, next to dietary matter, host-derived mucin might serve as a major nutrient source”
Quote in the paperNot a substantial claim - Interpretationown data
Individual communities are characterized by vast functional redundancies where several taxa potentially contribute to the TMA pool.
“demonstrate that individual communities are characterized by vast functional redundancies where several taxa potentially contribute to the TMA pool”
Quote in the paperSubstantial claim - Interpretationnone given
The negativity of 25% of HMP samples for cutC/D and cntA/B genes is most probably due to a lack of sequencing depth.
“which is most probably due to a lack of sequencing depth”
Quote in the paperNot a substantial claim - Premisecitation
TMA formation via cntA represents a distinctive branch of TMA synthesis.
“TMA formation via cntA represents a distinctive branch of TMA synthesis”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111:4268–73. source
Not checked in the free run.
- Interpretationown data
The distinct groups of TMA-producing gene pools are similar to enterotypes of global intestinal communities.
“similar to enterotypes of global intestinal communities [14]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174–80. source
Not checked in the free run.
- Interpretationown data
Functional predictions on respective reference genomes indicate broad, only partly overlapping ecological niches of individual strains.
“Functional predictions on respective reference genomes might explain those observations as they indicate broad, only partly overlapping ecological niches of individual strains”
Quote in the paperNot a substantial claim - Interpretationown data
Predictions presented here can only partially define functional characteristics of the TMA-producing community.
“predictions presented here can, hence, only partially define functional characteristics of the TMA-producing community”
Quote in the paperSubstantial claim - Interpretationown data
The TMA-synthesizing source is complex.
“it demonstrates the complexity of the TMA-synthesizing source”
Quote in the paperNot a substantial claim - Study design and conductreasoning
High degeneracy of primers can result in unspecific binding, particularly seen here for cntA.
“Since this can result in unspecific binding (in particular seen here for cntA), we suggest to quality control for every sample (see Additional file 4) in order to draw accurate conclusions on target abundance.”
Quote in the paperSubstantial claim - Interpretationreasoning
Gene loss rather than horizontal gene transfer is driving the disparate ability to transform choline into TMA within strains of the genus Clostridium XIVa.
“This indicates that gene loss rather than horizontal gene transfer is driving the disparate ability to transform choline into TMA within strains of this genus.”
Quote in the paperSubstantial claim - Premisereasoning
Most bacteria, including those belonging to Clostridium XIVa as well as main cntA-containing taxa, are able to utilize a multitude of energy sources in vivo.
“Most bacteria, also those belonging to Clostridium XIVa as well as main cntA-containing taxa are able to utilize a multitude of energy sources in vivo”
Quote in the paperNot a substantial claim - Interpretationown data
The lack of gene expression/TMA production investigations limits insights into actual functional activity.
“limiting insights into actual functional activity”
Quote in the paperSubstantial claim - Interpretationreasoning
TMA precursors contribute, most probably, only minutely to the entire substrate pool.
“where TMA precursors contribute, most probably, only minutely to the entire substrate pool, which is supported by the large CAZyme repertoires predicted for major TMA-producing taxa (see above)”
Quote in the paperNot a substantial claim- Rests on an assumption: Most bacteria, including those belonging to Clostridium XIVa as well as main cntA-containing taxa, are able to utilize a multitude of energy sources in vivo.
- Premisecitation
Ecophysiologic features of E. coli, the key player of cntA, are substantially different to those of the major cutC-exhibiting taxa.
“ecophysiologic features of its key player, E. coli, are substantially different to those of the major cutC-exhibiting taxa”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111:4268–73. source
Not checked in the free run.
- Interpretationreasoning
E. coli thrives in distinct niches/environments compared with bacteria containing cutC.
“demonstrate that this taxon thrives in distinct niches/environments compared with bacteria containing cutC”
Quote in the paperSubstantial claim - Premisecitation
Individuals on an omnivorous diet produced elevated TMAO levels in comparison to vegans or vegetarians following ingestion of l-carnitine.
“individuals on an omnivorous diet produced elevated TMAO levels in comparison to vegans or vegetarians following ingestion of l-carnitine [5]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Koeth R, Wang Z, Levison BS, Buffa J, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576–85. source
Not checked in the free run.
- Interpretationcitation
Specific conditions that select against cutC-containing bacteria might be compensated by an increase of taxa encoding CntA.
“Thus, specific conditions that select against the latter bacteria might be compensated by an increase of taxa encoding CntA [7]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111:4268–73. source
Not checked in the free run.
- Study design and conductown data
This study provides a diagnostic framework comprising comprehensive databases and gene-targeted assays that allowed, for the first time, the quantification and detailed characterization of the TMA-producing potential in human fecal samples.
“This study provides a diagnostic framework comprising comprehensive databases and gene-targeted assays that allowed, for the first time, the quantification and detailed characterization of the TMA-producing potential in human fecal samples”
Quote in the paperSubstantial claim - Study design and conductown data
Samples used in this study derived from volunteers that differed substantially in various characteristics such as age, BMI, and health status.
“Samples used in this study derived from volunteers that differed substantially in various characteristics such as age, BMI, and health status (Additional file 5)”
Quote in the paperSubstantial claim - Interpretationreasoning
The predicted profound amino acid auxotrophies of major players of the cutC-containing community suggest a link between the host diet, proliferation of TMA-producing strains, and concurrent TMA synthesis.
“The predicted profound amino acid auxotrophies of major players of the cutC-containing community (Additional file 10) suggest a link between the host diet, proliferation of TMA-producing strains, and concurrent TMA synthesis”
Quote in the paperSubstantial claim- Rests on an assumption: A nutrition rich in animal-derived products delivers both essential amino acids required for growth and high concentrations of the main TMA precursors choline and carnitine.
- The quote only partly states this claim. 3
- May combine two claims. 53
- Classified as probably not a substantial claim. 23
The quote only partly states this claim.
Findingown dataMulti-level screening of 67,134 genomes identified 6738 candidate genomes exhibiting cntA.
“Putative cntA genes were identified in 6738 genomes (491 dereplicated protein sequences)”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataMulti-level screening of 67,134 genomes identified 1107 candidate genomes exhibiting cutC.
“Putative cutC genes were detected in a total of 1107 genomes (454 dereplicated protein sequences)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPutative cutC genes belong to Proteobacteria, particularly Gamma- and Deltaproteobacteria, and Firmicutes, mainly Clostridia and some Bacilli, as well as a few Actinobacteria.
“Putative cutC genes were detected in a total of 1107 genomes (454 dereplicated protein sequences) that belong to Proteobacteria (in particular Gamma- and Deltaproteobacteria) and Firmicutes (mainly Clostridia and some Bacilli), as well as a few Actinobacteria”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataStrains are predicted to contain 101 ± 79 glycoside hydrolases, 41 ± 13 glycosyltransferases, 25 ± 17 carbohydrate-binding modules, 26 ± 13 carbohydrate esterases, and 4 ± 4 polysaccharide lyases.
“Overall, strains are predicted to contain 101 ± 79 glycoside hydrolases (GHs), 41 ± 13 glycosyltransferases (GTs), 25 ± 17 carbohydrate-binding modules (CBMs), 26 ± 13 carbohydrate esterases (CEs), and 4 ± 4 polysaccharide lyases (PLs).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAt higher cutoffs of 99 and 98% identity, several thousand cntA clusters were detected and richness drastically declined with decreasing identity cutoffs; only 55 and 14 total clusters were detected at 95 and 90% cutoff values, respectively.
“At higher cutoffs (99 and 98% identity), several thousand clusters were detected and richness drastically declined with decreasing identity cutoffs. For example, only 55 and 14 total clusters were detected at 95 and 90% cutoff values, respectively.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataAll cntA sequences obtained were similar to Gammaproteobacteria, particularly Escherichia/Shigella; closest match analysis revealed 98.1% being closely related to sequences from E. coli.
“In contrast, all cntA sequences obtained were similar to those previously observed in Gammaproteobacteria, in particular from Escherichia/Shigella (Fig. 2c); closest match analysis revealed 98.1% being closely related to sequences from E. coli (data not shown).”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataScreening of HMP contigs for cutC/D yielded similar results: only two samples contained contigs with decent sequence stretches indicating the presence of cutC/D, and those were nearly identical, >99% identity, to Clostridium sp. AT5 sequences.
“Screening of contigs provided by the Human Microbiome Project (HMP) for cutC/D sequences yielded similar results. Only two samples contained contigs with decent sequence stretches indicating the presence of cutC/D, and those were nearly identical (>99% identity) to Clostridium sp. AT5 sequences (data not shown).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOn average, 76 ± 18 clusters per sample at 90% nucleotide identity were observed, with the majority similar to Firmicutes, particularly Clostridium XIVa strains and Eubacterium sp. strain AB3007.
“On average, 76 ± 18 clusters per sample (90% nucleotide identity) were observed, where the majority was similar to genes previously observed in Firmicutes, in particular to those of Clostridium XIVa strains and Eubacterium sp. strain AB3007 (Fig. 2b).”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataCntA was quantified in 13 samples, with abundances ranging from 0.03 to 2.17% of bacteria possessing cntA, and only three samples had an abundance ≥0.5%.
“CntA was quantified in 13 samples displaying large abundance differences ranging from 0.03 to 2.17% of bacteria possessing cntA, with only three samples displaying an abundance ≥0.5%.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataAll revealed cutC candidates contain a single copy of cutC, except for seven genomes that display double entries.
“All revealed candidates contain a single copy of cutC, except for seven genomes that display double entries.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA major part of cutC sequences, especially clusters a-k, were only distantly related to reference sequences and formed separate clades; overall nucleotide similarity of cutC amplicons to references was low, 86% ± 7%.
“However, a major part of sequences, especially those of clusters a–k (Fig. 2b), were only distantly related to reference sequences and formed separate clades on the tree. Consequently, overall nucleotide similarity of cutC amplicons to reference sequences was low (86% ± 7%).”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataPutative cntA genes were identified in 6738 genomes, with the majority in Proteobacteria, especially Gammaproteobacteria mostly derived from Escherichia and Acinetobacter, some in Betaproteobacteria and Epsilonproteobacteria, and two sequences from Enterococcus sp.
“Putative cntA genes were identified in 6738 genomes (491 dereplicated protein sequences) where the majority was observed in Proteobacteria, especially Gammaproteobacteria (mostly derived from Escherichia and Acinetobacter), and some entries belonging to Betaproteobacteria and Epsilonproteobacteria (Fig. 1b, Additional file 1B, Additional file 2B). Two sequences were obtained from Enterococcus sp.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataGlobal feature analysis based on FIGfams largely reflected 16S rRNA gene phylogeny, where cutC-containing strains span the entire dendrogram and are dominated by three separate groups.
“Results of global feature analysis based on FIGfams largely reflected 16S rRNA gene phylogeny where cutC-containing strains span the entire dendrogram and are dominated by three separate groups (Additional file 10A).”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataOf those cntA clusters, a few, nine and one at 95 and 90% cutoffs respectively, were observed in >90% of all samples and comprised the majority of obtained sequences.
“Of those, a few clusters (nine and one, respectively) were observed in >90% of all samples comprising the majority of obtained sequences (Additional file 6B).”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataOverall identity of cntA amplicons to reference sequences was high, 99.5% ± 0.5%, and 3 ± 2 clusters per sample at 90% nucleotide identity were detected.
“Overall, the identity of amplicons to reference sequences was high (99.5% ± 0.5%), and with 3 ± 2 clusters (90% nucleotide identity) detected per sample, the gene diversity was much lower compared to that observed for cutC.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
FindingcitationReanalysis of metagenomes from Karlsson and colleagues indicated increased abundances of bacteria exhibiting the potential to produce TMA by about a factor of 2 in symptomatic atherosclerosis patients (n = 12) compared to healthy controls (n = 13), with median values of 0.39 and 0.11% in patients versus 0.22 and 0% in controls for cutC and cntA, respectively.
“Our results indicated increased abundances of bacteria exhibiting the potential to produce TMA (by about a factor of 2) in the patient group where the abundances of key genes of both pathways were elevated (median values of 0.39 and 0.11% (patient group) versus 0.22 and 0% (controls) for cutC and cntA, respectively, as a percentage of bacteria calculated to exhibit the genes) (Additional file 8).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245. source
Not checked in the free run.
May combine two claims.
FindingcitationThe established databases present a comprehensive update of previous cutC and cntA gene sequence collections, adding a multitude of new gene sequences.
“The established databases present a comprehensive update of previous cutC [9] and cntA [7] gene sequence collections adding a multitude of new gene sequences.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Campo AM, Bodea S, Hamer H. Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria. MBio. 2015;6:e00042–15.
Not checked in the free run.
- cites [7] Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111:4268–73. source
Not checked in the free run.
May combine two claims.
Findingown dataSamples enriched in other clusters linked to clade I form another group, whereas a few distant samples displayed high abundances of clusters tightly related with Clostridium XIVa strains.
“Samples enriched in other clusters linked to clade I form another group on the plot, whereas a few distant samples displayed high abundances of clusters tightly related with Clostridium XIVa strains.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataSome sequences in the databases are not expected to be amplified: the cntA forward primer does not match a few Betaproteobacteria, and a few cutC sequences observed in Streptococcus show ≥2 mismatches with the reverse primer.
“Nevertheless, some sequences comprised in our databases are not expected to be amplified, as the cntA forward primer does not match a few Betaproteobacteria, and in the case of cutC, a few sequences observed in Streptococcus show ≥2 mismatches with the reverse primer.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMost sequence reads displayed an identity of only 92.3% ± 7.1% for cutC and 96% ± 6.4% for cutD.
“However, most sequence reads displayed an identity of only 92.3% ± 7.1% and 96% ± 6.4% for cutC and cutD, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataC. phytofermentans, Clostridium sp. AT5, and Dorea sp. 5-2 cluster apart displaying ~55% functional similarity with members of the three main groups, while Eubacterium sp. strain AB3007, together with three additional strains, forms the outgroup sharing less than half of FIGfams with other strains.
“C. phytofermentans, Clostridium sp. AT5, and Dorea sp. 5-2 are clustering apart displaying ~55% functional similarity with members of the three main groups, while Eubacterium sp. strain AB3007, together with three additional strains, forms the outgroup sharing less than half of FIGfams with other strains.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor cutC/D, the majority of contigs from those samples were gene fragments, and only four assembled sequences, two for each gene, with length >50% of median reference gene lengths were obtained from two distinct samples.
“For cutC/D, the majority of contigs from those samples were gene fragments and only four assembled sequences (two for each gene) with a length >50% of median reference gene lengths were obtained (from two distinct samples).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGene-targeted assembly yielded sequences for cutC/D and cntA/B in only six and three samples, respectively, though at similar abundances as through BLAST search.
“Application of a gene-targeted assembly method yielded sequences for cutC/D and cntA/B in only six and three samples, respectively, though at similar abundances as through our BLAST search (Fig. 4).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEven at the low identity cutoff of 90%, the vast amount of cutC clusters was only detected in a minority of samples, with many being sample specific.
“Even at the low identity cutoffs of 90%, the vast amount of clusters was only detected in a minority of samples with many being sample specific.”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataAt a 95% cutoff, 1310 distinct cutC sequence types could be differentiated; only 41 were detected in the majority of samples, but they comprised ≥67% of obtained sequences.
“At a cutoff level of 95% 1310 distinct sequence types could be differentiated. Only a few of them (41) were detected in the majority of samples; however, they comprised the bulk of obtained sequences (≥67%).”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataCutC was enumerated in all 50 human fecal samples, with an average abundance of 0.16% ± 0.15% of the total community calculated to contain the gene.
“CutC was enumerated in all samples, and an average abundance of 0.16% ± 0.15% bacteria of the total community was calculated to contain the gene.”
Quote in the paperSubstantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataMembers of clade I, defined by clusters a-d, are separated where main clusters a and b are not connected to each other nor to other phylogenetically related clusters, whereas members from clades II (g) and III (j) are located in the same module linked to other clusters from those clades.
“Members of clade I (defined by clusters a–d from Fig. 2b) are separated where the main clusters a and b are not connected to each other nor to other phylogenetically related clusters, whereas members from clades II (g) and III (j) are located in the same module linked to other clusters from those clades.”
Quote in the paperNot a substantial claim- Rests on an assumption: The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
May combine two claims.
Findingown dataReads indicating the presence of cntA/B were nearly identical to references, 99.6% ± 1.1% and 99.8% ± 0.8% for cntA and cntB, respectively, and predominantly related to Gammaproteobacteria, especially Escherichia/Shigella and Klebsiella.
“In contrast, reads indicating the presence of cntA/B were nearly identical to references (99.6% ± 1.1% and 99.8% ± 0.8% for cntA and cntB, respectively) and predominantly related to Gammaproteobacteria, in particular to Escherichia/Shigella and Klebsiella.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataOn average, 98.2% (cutC) and 92.5% (cntA) of all merged sequences passed the initial quality steps.
“On average, 98.2% (cutC) and 92.5% (cntA) of all merged sequences passed these initial steps”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationColonization of the mouse gut with a specific consortium of CutC-encoding human isolates results in TMA synthesis and subsequent TMAO accumulation in serum.
“Another recent study [10] demonstrated that colonization of the mouse gut with a specific consortium of CutC-encoding human isolates results in TMA synthesis and subsequent TMAO accumulation in the serum of animals”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability. MBio. 2015;6:e02481–14. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationFunctionality of CntA/B and YeaX/Y has been shown for Acinetobacter baumannii and Escherichia coli, where both genes cntA/yeaX and cntB/yeaW are required for TMA formation.
“Functionality has been shown for Acinetobacter baumannii and Escherichia coli where both genes cntA/yeaX and cntB/yeaW are required for the formation of TMA.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTMAO promotes atherogenesis through formation of foam cells and reduction of reverse cholesterol transport from atherosclerotic plaque.
“A mechanistic model has been formulated proposing that TMAO promotes atherogenesis through the formation of foam cells (lipid-laden macrophages) and a reduction of the reverse cholesterol transport from the atherosclerotic plaque [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Koeth R, Wang Z, Levison BS, Buffa J, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576–85. source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationTwo major TMA-synthesis pathways have been described: CutC/CutD takes choline as substrate, and CntA/B acts on carnitine and gamma-butyrobetaine.
“Two major TMA-synthesis pathways have been described with a specific glycyl radical enzyme, the choline TMA-lyase (CutC) and its activator CutD [6], that takes choline as a substrate and a two-component Rieske-type oxygenase/reductase (CntA/B) [7], which acts on carnitine and its derivative gamma-butyrobetaine, as the key enzymes.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci U S A. 2012;109:21307–12. source
Not checked in the free run.
- cites [7] Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci U S A. 2014;111:4268–73. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe choline utilization cluster including cutC/D is widely but discontinuously distributed across Firmicutes, Actinobacteria, and Proteobacteria.
“Campo and colleagues have shown that the so-called choline utilization cluster, which includes cutC/D among other genes involved in anaerobic choline metabolism, is widely, but discontinuously, distributed across various taxa belonging to Firmicutes, Actinobacteria, and Proteobacteria [9].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Campo AM, Bodea S, Hamer H. Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria. MBio. 2015;6:e00042–15.
Not checked in the free run.
May combine two claims.
Study design and conductown dataIn silico analysis suggested that the developed primers target 93% of unique cutC genes and 96% of unique cntA genes, allowing one mismatch in each primer.
“In silico analysis on coverage of developed primers suggested that a broad range of cutC and cntA gene sequences are targeted, namely 93 and 96% of all unique cutC and cntA genes, respectively (allowing for one mismatch in each primer).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataFor both genes, metagenomic analysis suggested that sequences not targeted by the assays do not play an important role in the colonic TMA-producing communities, as not a single read was related to any of those reference sequences.
“However, for both genes, metagenomic analysis suggested that sequences not targeted by our assays do not play an important role in the colonic TMA-producing communities as not a single read was related to any of those reference sequences.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe yeaW gene displays close sequence identity, 74%, to the cntA model sequence from A. baumannii and is arranged in similar operons that additionally encode a reductase (yeaX and cntB) as well as a betaine/carnitine/choline transporter.
“However, the yeaW gene displays close sequence identity (74%) to the cntA model sequence from A. baumannii and is arranged in similar operons that additionally encode a reductase (yeaX and cntB, respectively) as well as a betaine/carnitine/choline transporter”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, et al. γ-Butyrobetaine is a proantherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 2014;20:799–812. source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationFor both enzymes, promiscuity to transform carnitine and butyrobetaine at similar rates was shown.
“and for both enzymes, promiscuity to transform carnitine and butyrobetaine at similar rates was shown (yeaW/X was reported to act on choline and to a lesser extent on betaine as well).”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe gene-targeted assays encompass key genes of the two major TMA-synthesis pathways and target a broad range of distinct taxa.
“Our gene-targeted assays encompass key genes of the two major TMA-synthesis pathways and target a broad range of distinct taxa.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataPrimer coverage is thorough, and amplification as well as quantification of numerous distinct target sequences at similar levels was confirmed.
“Primer coverage is thorough, and amplification as well as quantification of numerous distinct target sequences at similar levels was confirmed.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataqPCR on one-third diluted samples indicated quantities of 40.6% ± 12.2% and 39.9% ± 22.2% of undiluted samples for cutC and cntA, respectively, evidencing that PCR mixtures were devoid of interfering ingredients.
“The qPCR on one third diluted samples indicated quantities of 40.6% ± 12.2% and 39.9% ± 22.2% of undiluted samples for cutC and cntA (five samples were on the borderline of detection), respectively, evidencing that the PCR mixtures were devoid of any interfering ingredients.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataFor cutC qPCR, one major band with the expected size was detected in all samples; for a few samples, some very faint unspecific bands were additionally visible.
“For cutC, one major band with the expected size was detected in all samples; for a few samples, some very faint unspecific bands were additionally visible.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataA cutoff of 906.4, the median HMM score of the two sequences framing the drop, was set, and entries above that cutoff were considered true cutC sequences.
“Hence, a cutoff of 906.4, representing the median HMM score of the two sequences that frame that drop, was set, and all entries above that cutoff were considered as true cutC sequences.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTMA producers constitute members of the core gut community, though at very low abundances.
“suggesting that TMA producers constitute members of the core gut community, though at very low abundances”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenSequencing depth in the Karlsson datasets was roughly 1 order of magnitude lower compared to HMP datasets, hampering accurate analyses.
“Sequencing depth was roughly 1 order of magnitude lower compared to HMP datasets hampering accurate analyses.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe chosen HMM similarity cutoff for cntA was set at an obvious HMM score drop, which correlated less strongly with other parameters than the cutC analysis.
“Similar to cutC, the chosen HMM similarity cutoff was set at an obvious HMM score drop that, however, correlated less strongly with other parameters investigated in comparison with the cutC analysis shown above.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThirty-four lower-scoring sequences from Bacilli were not considered true cntA because they are neither closely phylogenetically related to top-scoring sequences nor exhibit syntenic cntB sequences.
“Specifically, 34 lower-scoring sequences from Bacilli are neither in close phylogenetic relation to the top-scoring sequences nor do they exhibit syntenic cntB sequences and were, hence, not considered as true cntA”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataOverall, Clostridium XIVa cutC protein sequences form a monophyletic clade, where phylogenetic relations, with a few exceptions, resemble those derived from 16S rRNA gene sequence analysis, suggesting a close linkage between host phylogeny and cutC gene evolution.
“Overall, Clostridium XIVa cutC protein sequences form a monophyletic clade (Additional file 1), where phylogenetic relations, with a few exceptions such as Clostridium phytofermentans, Clostridium sp. AT5, and Dorea sp. 5-2, resemble those derived from 16S rRNA gene sequence analysis (Additional file 9B) suggesting a close linkage between host phylogeny and cutC gene evolution.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataA quantification limit of 5 × 103 genome copies per reaction for both genes was determined; below those concentrations, primer dimers prevented accurate target enumeration.
“Based on genomic sequences that were used as standards in the developed assays (see the “Methods” section), a quantification limit of 5 × 103 genome copies per reaction for both genes was determined. Below those concentrations, the formation of primer dimers did not allow for accurate target enumeration (Additional file 3A, B).”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataFor both genes, all tested synthetic sequences were amplified and, with a few exceptions, quantified at similar abundance levels.
“For both genes, all tested synthetic sequences were amplified and, with a few exceptions, quantified at similar abundance levels (Additional file 3C, D ).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataGiven that 16S rRNA gene sequence analysis cannot adequately predict the TMA-producing potential and metagenomic data lack depth to satisfactorily resolve this low-abundance functional community, the assays developed here represent the most proper technique to investigate intestinal TMA-producing communities.
“Given that 16S rRNA gene sequence analysis cannot adequately predict the TMA-producing potential (Additional file 7) and metagenomic data lack depth to satisfactorily resolve this low abundant functional community, the assays developed here represent the most proper technique to investigate intestinal TMA-producing communities.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataIn the cntA qPCR, two samples (10 and 19) showed a single unspecific band and were not considered positive for the gene; one sample displayed two bands.
“In the cntA qPCR, two samples (10 and 19) showed a single unspecific band (sequencing confirmed them as non-target (data not shown)) and samples were, hence, not considered as positive for the gene; one sample displayed two bands.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataDue to the low abundance of bacteria encoding a TMA-producing potential, sequencing depth was not enough to ensure adequate coverage for assembly; BLAST searches yielded on average only 56 and 13 reads for cutC and cutD, respectively, even for HMP datasets with on average >108 reads.
“Thus, due to the low abundance of bacteria encoding a TMA-producing potential, sequencing depth was not enough to ensure adequate coverage for assembly (the BLAST searches yielded on average only 56 and 13 reads for cutC and cutD, respectively), even for HMP datasets where an ample amount of reads (on average >108) is provided.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenOur developed assays are applicable in high throughput.
“Our developed assays are applicable in high throughput”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenA nutrition rich in animal-derived products delivers both essential amino acids required for growth and high concentrations of the main TMA precursors choline and carnitine.
“a nutrition that is rich in animal-derived products delivers both essential amino acids required for growth and high concentrations of the main TMA precursors choline and carnitine”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe metagenomic methodology used in the reanalysis provided only limited insights and together with a low sample size did not allow for extraction of statistically significant results.
“though the methodology used, i.e., metagenomics, provided only limited insights and together with a low sample size it did not allow for extraction of statistically significant results (Additional file 8)”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningThe results may assist the design of subject-specific therapies that prevent TMA synthesis and the development of disease.
“may assist the design of subject-specific therapies that prevent TMA synthesis and the development of disease”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningThe diversity of the sample population allowed insights into the TMA-producing community from a diverse population but hindered revealing specific host factors that govern its proliferation.
“which allowed insights into the TMA-producing community from a diverse population, but hindered revealing specific host factors that govern its proliferation”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPatients suffering from trimethylaminuria are often treated by adapting to a vegan diet in order to limit the intake of dietary animal products that promote TMA production such as egg yolk and various meats.
“patients suffering from trimethylaminuria, where TMA accumulates in various body fluids, are often treated by adapting to a vegan diet in order to limit the intake of dietary animal products that promote TMA production such as egg yolk and various meats [15]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Christodoulou J. Trimethylaminuria: an under-recognised and socially debilitating metabolic disorder. J Paediatr Child Health. 2012;48:2011–3. source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenOnly samples displaying both genes of a pathway were considered for analysis.
“Only samples displaying both genes of a pathway were considered for analysis”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenResults are expressed as averages of three independent experiments.
“Results are expressed as averages of three independent experiments”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningResults of the developed assays together with presented functional predictions of major taxa involved provide crucial information for uncovering factors limiting growth of TMA producers in the gut.
“Results of the developed assays together with presented functional predictions of major taxa involved provide crucial information for uncovering factors limiting growth of TMA producers in the gut”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationA modified forward primer was used to ensure adequate amplification, including taxa previously underrepresented using conventional primers.
“To ensure adequate amplification, including taxa that were previously underrepresented using conventional primers that target the V1-2 region such as Bifidobacteria [29], a modified forward primer was used”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Walker AW, Martin JC, Scott P, Parkhill J, Flint HJ, Scott KP. 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome. 2015;3:26. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA correlation between dietary habits and production of TMAO was previously established.
“a correlation between dietary habits and production of TMAO was previously established”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Koeth R, Wang Z, Levison BS, Buffa J, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19:576–85. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenOnly clusters that exhibit ≥5 sequence counts were considered, and the data was rarified to equal depth.
“Only clusters that exhibit ≥5 sequence counts were considered, and the data was rarified to equal depth”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe database construction cycle was repeated three times to ensure construction of robust models.
“this cycle was repeated three times to ensure construction of robust models”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor cntA, sample 3 was omitted as >99% of obtained sequences failed FrameBot analysis.
“For cntA, sample 3 was omitted as >99% of obtained sequences (from 13,095) failed FrameBot analysis”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenTop hits that covered ≥70 bp and displayed ≥70% identity to a reference were considered for analysis where both genes of each pathway had to be detected for a positive result.
“Top hits (based on e-value) that covered ≥70 bp and displayed ≥70% identity to a reference were considered for analysis where both genes of each pathway had to be detected for a positive result”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe study only targeted the TMA-producing potential by quantifying respective gene abundances, and no investigations on gene expression/TMA production were performed.
“we only targeted the TMA-producing potential by quantifying respective gene abundances, and no investigations on gene expression/TMA production were performed”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenOnly significant correlations (p < 0.01) displaying a ρ ≥ 0.5 and a false-discovery correction q-value <0.01 between clusters that were detected in at least 50% of samples were considered for analysis.
“Only significant correlations (p < 0.01) displaying a ρ ≥ 0.5 and a false-discovery correction q-value <0.01 between clusters that were detected in at least 50% of samples were considered for analysis”
Quote in the paperSubstantial claim
The paper relies on this without support.
The TMA-producing communities in fecal samples are representative of the colonic TMA-producing communities in humans.
“The developed assays were used to characterize the TMA-producing communities in the fecal samples of 50 individuals.”
The paper relies on this without support.
A nutrition rich in animal-derived products delivers both essential amino acids required for growth and high concentrations of the main TMA precursors choline and carnitine.
“a nutrition that is rich in animal-derived products delivers both essential amino acids required for growth and high concentrations of the main TMA precursors choline and carnitine”
The paper relies on this without support.
Most bacteria, including those belonging to Clostridium XIVa as well as main cntA-containing taxa, are able to utilize a multitude of energy sources in vivo.
“Most bacteria, also those belonging to Clostridium XIVa as well as main cntA-containing taxa are able to utilize a multitude of energy sources in vivo”
The paper relies on this without support.
Major health-promoting butyrate producers previously classified as belonging to Clostridium XIVa such as Eubacterium rectale and Roseburia represent members of other genera that do not comprise any known CutC-encoding strains.
“major health-promoting butyrate producers previously classified as belonging to Clostridium XIVa such as Eubacterium rectale and Roseburia represent members of other genera that does not comprise any known CutC-encoding strains”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Choline TMA-lyase was only present in 26% of individuals.
“it was only present in 26% of individuals”
From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Rath et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
16S forward-primer degeneracy does not match its sequence
MinorThe 16S forward primer has four degenerate positions: R, H, Y, and M. These yield 2 × 3 × 2 × 2 = 24 combinations, not the stated 32.
“total combinations—cutC_F, 32; cutC_R, 16; cntA_F, 32; cntA_R, 512; 16S_F, 32; 16S_R, 1”
“| 16S | AGRGTTHGATYMTGGCTCAG | TGCTGCCTCCCGTAGGAGT |”
Cites
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,013 · see citing works
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,946 · see citing works
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894 · see citing works
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,455 · see citing works
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548 · see citing works
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · see citing works
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386 · see citing works
Ribosomal Database Project: data and tools for high throughput rRNA analysis
Cole, J. R., Wang, Q., Fish, J. A., Chai, B., McGarrell, D. M., Sun, Y., Brown, C. T., Porras‐Alfaro, A., Kuske, C. R., & Tiedje, J. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1244 · Cited by 4,322 · see citing works
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,402 · see citing works
A framework for human microbiome research
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11209 · Cited by 2,650 · see citing works
dbCAN: a web resource for automated carbohydrate-active enzyme annotation
Yin, Y., Mao, X., Yang, J., Chen, X., Mao, F., & Xu, Y. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks479 · Cited by 1,800 · see citing works
Analysis Tool Web Services from the EMBL-EBI
McWilliam, H., Li, W., Uludağ, M., Squizzato, S., Park, Y. M., Buso, N., Cowley, A., & López, R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt376 · Cited by 1,636 · see citing works
Symptomatic atherosclerosis is associated with an altered gut metagenome
Karlsson, F. H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F., & Nielsen, J. (2012) · Nature Communications · doi:10.1038/ncomms2266 · Cited by 1,371 · cited 2× · see citing works
“In order to gain insights into TMA-producing communities of atherosclerotic individuals, we reanalyzed metagenomes provided by Karlsson and colleagues [12], who specifically investigated the microbial composition of symptomatic atherosclerosis patients (n = 12) and compared them to healthy control samples (n = 13).”
IMG: the integrated microbial genomes database and comparative analysis system
Markowitz, V. M., Chen, I.-M. A., Palaniappan, K., Chu, K., Szeto, E., Grechkin, Y., Ratner, A., Jacob, B., Huang, J., Williams, P. G., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1044 · Cited by 1,315 · see citing works
Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data
Vital, M., Howe, A. C., & Tiedje, J. M. (2014) · mBio · doi:10.1128/mbio.00889-14 · Cited by 1,189 · see citing works
Self-citationRomano, K. A., Vivas, E. I., Amador-Noguez, D., & Rey, F. E. (2015) · mBio · doi:10.1128/mbio.02481-14 · Cited by 777 · see citing works
Wang, J.-J., Tang, H., Zhang, C.-H., Zhao, Y., Derrien, M., Rocher, E., Vlieg, J. V. V. H., Strissel, K., Zhao, L.-P., Obin, M., et al. (2014) · The ISME Journal · doi:10.1038/ismej.2014.99 · Cited by 774 · see citing works
Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme
Craciun, S., & Balskus, E. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215689109 · Cited by 701 · see citing works
γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Koeth, R. A., Levison, B. S., Culley, M. K., Buffa, J. A., Wang, Z., Gregory, J. C., Org, E., Wu, Y., Li, L., Smith, J. D., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.10.006 · Cited by 546 · see citing works
Trøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464 · see citing works
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Stubbs, J. R., House, J. A., Ocque, A. J., Zhang, S., Johnson, C., Kimber, C., Schmidt, K., Gupta, A., Wetmore, J. B., Nolin, T. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014111063 · Cited by 450 · see citing works
Complex Carbohydrate Utilization by the Healthy Human Microbiome
Cantarel, B. L., Lombard, V., & Henrissat, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028742 · Cited by 378 · see citing works
Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota
Zhu, Y., Jameson, E., Crosatti, M., Schäfer, H., Rajakumar, K., Bugg, T. D. H., & Chen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316569111 · Cited by 372 · see citing works
Demonstrating microbial co-occurrence pattern analyses within and between ecosystems
Williams, R. J., Howe, A., & Hofmockel, K. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00358 · Cited by 363 · see citing works
Wang, Q., Quensen, J. F., Fish, J. A., Lee, T. K., Sun, Y., Tiedje, J. M., & Cole, J. R. (2013) · mBio · doi:10.1128/mbio.00592-13 · Cited by 323 · see citing works
Walker, A. W., Martin, J. C., Scott, P., Parkhill, J., Flint, H. J., & Scott, K. P. (2015) · Microbiome · doi:10.1186/s40168-015-0087-4 · Cited by 273 · see citing works
Martínez-del Campo, A., Bodea, S., Hamer, H. A., Marks, J. A., Haiser, H. J., Turnbaugh, P. J., & Balskus, E. P. (2015) · mBio · doi:10.1128/mbio.00042-15 · Cited by 224 · see citing works
Microbiology Meets Big Data: The Case of Gut Microbiota–Derived Trimethylamine
Falony, G., Vieira-Silva, S., & Raes, J. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104422 · Cited by 187 · see citing works
Vital, M., Gao, J., Rizzo, M., Harrison, T. M., & Tiedje, J. M. (2014) · The ISME Journal · doi:10.1038/ismej.2014.179 · Cited by 125 · see citing works
Self-citationXander: employing a novel method for efficient gene-targeted metagenomic assembly
Wang, Q., Fish, J. A., Gilman, M., Sun, Y., Brown, C. T., Tiedje, J. M., & Cole, J. R. (2015) · Microbiome · doi:10.1186/s40168-015-0093-6 · Cited by 103 · see citing works
Microbial Community Analysis with Ribosomal Gene Fragments from Shotgun Metagenomes
Guo, J., Cole, J. R., Zhang, Q., Brown, C. T., & Tiedje, J. M. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.02772-15 · Cited by 75 · see citing works
Trimethylaminuria: An under‐recognised and socially debilitating metabolic disorder
Christodoulou, J. (2012) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2010.01978.x · Cited by 32 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Beghini, F., McIver, L. J., Blanco-Míguez, A., Dubois, L., Asnicar, F., Maharjan, S., Mailyan, A., Manghi, P., Scholz, M., Thomas, A. M., et al. (2021) · eLife · doi:10.7554/elife.65088 · Cited by 2,303 · see citing works
Oliphant, K., & Allen-Vercoe, E. (2019) · Microbiome · doi:10.1186/s40168-019-0704-8 · Cited by 1,327 · see citing works
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,246 · see citing works
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R. D., Pontefract, B., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2019) · Nutrients · doi:10.3390/nu11071613 · Cited by 1,107 · see citing works
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030 · see citing works
MicroRNAs and complex diseases: from experimental results to computational models
Chen, X., Xie, D., Zhao, Q., & You, Z. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx130 · Cited by 640 · see citing works
Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential
Roberts, A. B., Gu, X., Buffa, J. A., Hurd, A. G., Wang, Z., Zhu, W., Gupta, N., Skye, S. M., Cody, D. B., Levison, B. S., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0128-1 · Cited by 552 · see citing works
Intestinal Microbiota in Cardiovascular Health and Disease
Tang, W. H. W., Bäckhed, F., Landmesser, U., & Hazen, S. L. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.024 · Cited by 508 · see citing works
Colonic Butyrate-Producing Communities in Humans: an Overview Using Omics Data
Vital, M., Karch, A., & Pieper, D. H. (2017) · mSystems · doi:10.1128/msystems.00130-17 · Cited by 487 · see citing works
Self-citationGut microbiota derived metabolites in cardiovascular health and disease
Wang, Z., & Zhao, Y. (2018) · Protein & Cell · doi:10.1007/s13238-018-0549-0 · Cited by 475 · see citing works
Microbial modulation of cardiovascular disease
Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440 · see citing works
Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery
Kriss, M. S., Hazleton, K. Z., Nusbacher, N. M., Martin, C. G., & Lozupone, C. (2018) · Current Opinion in Microbiology · doi:10.1016/j.mib.2018.07.003 · Cited by 416 · see citing works
Wang, H., Rong, X., Zhao, G., Zhou, Y., Xiao, Y., Ma, D., Jin, X., Wu, Y., Yan, Y., Yang, H., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.02.010 · Cited by 411 · see citing works
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Verhaar, B. J. H., Prodan, A., Nieuwdorp, M., & Muller, M. (2020) · Nutrients · doi:10.3390/nu12102982 · Cited by 411 · see citing works
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 347 · see citing works
Mirji, G., Worth, A., Bhat, S. A., El Sayed, M., Kannan, T., Goldman, A. R., Tang, H.-Y., Liu, Q., Auslander, N., Dang, C. V., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abn0704 · Cited by 327 · see citing works
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Koeth, R. A., Lam-Galvez, B. R., Kirsop, J., Wang, Z., Levison, B. S., Gu, X., Copeland, M. F., Bartlett, D., Cody, D. B., Dai, H. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94601 · Cited by 327 · see citing works
Gut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319 · see citing works
Ji, Y. S., Gao, Y. Z., Chen, H., Yin, Y., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11092062 · Cited by 292 · see citing works
van den Munckhof, I., Kurilshikov, A., ter Horst, R., Riksen, N. P., Joosten, L. A. B., Zhernakova, A., Fu, J., Keating, S. T., Netea, M. G., Graaf, J. D., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12750 · Cited by 275 · see citing works
Microbial impact on cholesterol and bile acid metabolism: current status and future prospects
Kriaa, A., Bourgin, M., Potiron, A., Mkaouar, H., Jablaoui, A., Gérard, P., Maguin, E., & Rhimi, M. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r088989 · Cited by 264 · see citing works
Liu, Y., & Dai, M. (2020) · Mediators of Inflammation · doi:10.1155/2020/4634172 · Cited by 231 · see citing works
The promise of the gut microbiome as part of individualized treatment strategies
Schupack, D. A., Mars, R. A. T., Voelker, D. H., Abeykoon, J. P., & Kashyap, P. C. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00499-1 · Cited by 217 · see citing works
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Canyelles, M., Borràs, C., Rotllán, N., Tondo, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031940 · Cited by 211 · see citing works
Arias, N., Arboleya, S., Allison, J., Kaliszewska, A., Higarza, S. G., Gueimonde, M., & Arias, J. L. (2020) · Nutrients · doi:10.3390/nu12082340 · Cited by 199 · see citing works
Ma, S., Tong, Q., Lin, Y., Pan, L., Fu, J., Peng, R., Zhang, X., Zhao, Z., Li, Y., Yu, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01027-6 · Cited by 193 · see citing works
Canyelles, M., Tondo, M., Cedó, L., Farràs, M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103228 · Cited by 194 · see citing works
The germ-organ theory of non-communicable diseases
Byndloss, M. X., & Bäumler, A. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.158 · Cited by 185 · see citing works
Cai, Y., Huang, F., Lao, X., Lu, Y., Gao, X. J., Alolga, R. N., Yin, K., Zhou, X., Wang, Y., Liu, B., et al. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00273-4 · Cited by 178 · see citing works
Hrncir, T., Hrncirova, L., Kverka, M., Hromádka, R., Machova, V., Trckova, E., Kostovcikova, K., Králíčková, P., Krejsek, J., & Tlaskalová‐Hogenová, H. (2021) · Microorganisms · doi:10.3390/microorganisms9050957 · Cited by 179 · see citing works
Fu, B. C., Hullar, M. A. J., Randolph, T. W., Franke, A. A., Monroe, K. R., Cheng, I. C., Wilkens, L. R., Shepherd, J., Madeleine, M. M., Marchand, L. L., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa015 · Cited by 171 · see citing works
Role of gut microbiota in identification of novel TCM-derived active metabolites
Lin, T., Lu, C., Lai, W.-F., Wu, T., Lu, J., Chen, Y.-M., Tzeng, C., Liu, H., Wei, H., & Lai, H. (2020) · Protein & Cell · doi:10.1007/s13238-020-00784-w · Cited by 175 · see citing works
Sharpton, S. R., Ajmera, V. H., & Loomba, R. S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.065 · Cited by 170 · see citing works
Psychotropics and the Microbiome: a Chamber of Secrets…
Cussotto, S., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5185-8 · Cited by 169 · see citing works
The Role of Oral Microbiota in Intra-Oral Halitosis
Hampelska, K., Jaworska, M. M., Babalska, Z. Ł., & Karpiński, T. M. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082484 · Cited by 169 · see citing works
Wu, W., Chen, C., Liu, P., Panyod, S., Liao, B., Chen, P.-C., Kao, H., Kuo, H., Kuo, C., Chiu, T. H. T., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317155 · Cited by 156 · see citing works
Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis
Thye, A. Y.-K., Bah, Y.-R., Law, J. W.-F., Tan, L. T.-H., He, Y.-W., Wong, S.-H., Thurairajasingam, S., Chan, K.-G., Lee, L.-H., & Letchumanan, V. (2022) · Biomedicines · doi:10.3390/biomedicines10051037 · Cited by 156 · see citing works
Diet-Gut Microbiota Interactions and Gestational Diabetes Mellitus (GDM)
Ponzo, V., Fedele, D., Goitre, I., Leone, F., Lezo, A., Monzeglio, C., Finocchiaro, C., Ghigo, E., & Bo, S. (2019) · Nutrients · doi:10.3390/nu11020330 · Cited by 155 · see citing works
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular disease
Ascher, S., & Reinhardt, C. (2017) · European Journal of Immunology · doi:10.1002/eji.201646879 · Cited by 150 · see citing works
Li, X., Su, C., Jiang, Z., Yang, Y., Zhang, Y., Yang, M., Zhang, X., Du, Y., Zhang, J., Wang, L., et al. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00205-8 · Cited by 153 · see citing works
Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?
Papandreou, C., Moré, M. I., & Bellamine, A. (2020) · Nutrients · doi:10.3390/nu12051330 · Cited by 150 · see citing works
Haak, B. W., Westendorp, W. F., van Engelen, T. S. R., Brands, X., Brouwer, M. C., Vermeij, J., Hugenholtz, F., Verhoeven, A., Derks, R. J. E., Giera, M. A., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00863-4 · Cited by 144 · see citing works
Gawalko, M. M., Agbaedeng, T. A., Saljic, A., Müller, D. N., Wilck, N., Schnabel, R. B., Penders, J., Rienstra, M., Gelder, I. C. V., Jespersen, T., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab292 · Cited by 144 · see citing works
Intestinal microbiota of layer hens and its association with egg quality and safety
Dai, D., Qi, G., Wang, J., Zhang, H., Qiu, K., & Wu, S. (2022) · Poultry Science · doi:10.1016/j.psj.2022.102008 · Cited by 139 · see citing works
Li, J., Li, Y., Ivey, K. L., Wang, D. D., Wilkinson, J. E., Franke, A., Lee, K. H., Chan, A., Huttenhower, C., Hu, F. B., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-322473 · Cited by 137 · see citing works
Ridlon, J. M., Devendran, S., Alves, J. M. P., Doden, H. L., Wolf, P. G., Pereira, G. V., Ly, L. K., Volland, A., Takei, H., Nittono, H., et al. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1618173 · Cited by 137 · see citing works
Cheng, H., Liu, J., Tan, Y., Feng, W., & Peng, C. Y. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.10.003 · Cited by 137 · see citing works
Potential TMA-Producing Bacteria Are Ubiquitously Found in Mammalia
Rath, S., Rud, T., Pieper, D. H., & Vital, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02966 · Cited by 130 · see citing works
Self-citationMan, A. W. C., Zhou, Y., Xia, N., & Li, H. (2020) · Nutrients · doi:10.3390/nu12103054 · Cited by 136 · see citing works
Chen, Y.-R., Zheng, H.-M., Zhang, G.-X., Chen, F.-L., Chen, L.-D., & Yang, Z.-C. (2020) · Scientific Reports · doi:10.1038/s41598-020-66369-z · Cited by 127 · see citing works
The Gut–Liver Axis in the Control of Energy Metabolism and Food Intake in Animals
Ringseis, R., Geßner, D. K., & Eder, K. (2019) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021419-083852 · Cited by 127 · see citing works
Ortega, M. A., Álvarez-Mon, M. Á., Montero, C. G., Fraile‐Μartinez, O., Guijarro, L. G., Lahera, G., Monserrat, J., Valls, P., Mora, F., Rodríguez–Jiménez, R., et al. (2022) · Metabolites · doi:10.3390/metabo12010050 · Cited by 125 · see citing works
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data
Kircher, B., Woltemate, S., Gutzki, F. M., Schlüter, D., Geffers, R., Bähre, H., & Vital, M. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2149019 · Cited by 120 · see citing works
Self-citationGut microbiota and bone metabolism
Lu, L., Chen, X., Liu, Y., & Yu, X. (2021) · The FASEB Journal · doi:10.1096/fj.202100451r · Cited by 120 · see citing works
Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective
Valles-Colomer, M., Menni, C., Berry, S. E., Valdes, A. M., Spector, T. D., & Segata, N. (2023) · Nature Medicine · doi:10.1038/s41591-023-02260-4 · Cited by 114 · see citing works
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes
León‐Mimila, P., Villamil‐Ramírez, H., Li, X. S., Shih, D. M., Hui, S. T. Y., Ocampo‐Medina, E., López-Contreras, B. E., Morán‐Ramos, S., Olivares-Arévalo, M., Grandini-Rosales, P., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.07.010 · Cited by 110 · see citing works
Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood
Bavineni, M., Wassenaar, T. M., Agnihotri, K., Ussery, D. W., Lüscher, T. F., & Mehta, J. L. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz025 · Cited by 102 · see citing works
Metagenomic Insights into the Degradation of Resistant Starch by Human Gut Microbiota
Vital, M., Howe, A., Bergeron, N., Krauss, R. M., Jansson, J. K., & Tiedje, J. M. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.01562-18 · Cited by 98 · see citing works
Self-citationGut Microbiota and Atherosclerosis—Focusing on the Plaque Stability
Shen, X., Li, L., Sun, Z., Zang, G., Zhang, L., Shao, C., & Wang, Z. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.668532 · Cited by 99 · see citing works
Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
Chen, X., Zhang, H., Ren, S., Ding, Y.-N., Remex, N. S., Bhuiyan, M. S., Qu, J.-H., & Tang, X. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002206 · Cited by 98 · see citing works
Pathogenic functions of host microbiota
Rath, S., Rud, T., Karch, A., Pieper, D. H., & Vital, M. (2018) · Microbiome · doi:10.1186/s40168-018-0542-0 · Cited by 96 · see citing works
Self-citationEmerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer
Jalandra, R., Dalal, N., Yadav, A. K., Verma, D., Sharma, M., Singh, R. K., Khosla, A., Kumar, A., & Solanki, P. R. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11582-7 · Cited by 255 · see citing works
Diet-gut microbiota interactions on cardiovascular disease
Zhang, X., & Gérard, P. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.028 · Cited by 94 · see citing works
Leustean, A. M., Ciocoiu, M., Sava, A. C., Costea, C. F., Floria, M., Tărniceriu, C. C., & Tănase, D. M. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5205126 · Cited by 92 · see citing works
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Ye, Z., Lulu, C., Xiangchang, Z., Fang, Q., Binjie, Z., Chunyang, L., Rao, T., & Dongsheng, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929262 · Cited by 90 · see citing works
Gut Microbiota and Atherosclerosis
Li, D. Y., & Tang, W. H. W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0675-9 · Cited by 88 · see citing works
Microbiota and Malodor—Etiology and Management
Mogilnicka, I., Bogucki, P., & Ufnal, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082886 · Cited by 94 · see citing works
Microbiome and health implications for ethnic minorities after enforced lifestyle changes
Keohane, D. M., Ghosh, T. S., Jeffery, I. B., Molloy, M. G., O’Toole, P. W., & Shanahan, F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0963-8 · Cited by 87 · see citing works
Andrikopoulos, P., Aron‐Wisnewsky, J., Chakaroun, R., Myridakis, A., Forslund, S. K., Nielsen, T., Adriouch, S., Holmes, B., Chilloux, J., Vieira‐Silva, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39824-4 · Cited by 86 · see citing works
Zhou, Y., Zhang, Y., Jin, S., Lv, J., Li, M., & Feng, N. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117031 · Cited by 92 · see citing works
Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health
Caradonna, E., Abate, F., Schiano, E., Paparella, F., Ferrara, F., Vanoli, E., Difruscolo, R., Goffredo, V. M., Amato, B., Setacci, C., et al. (2025) · Metabolites · doi:10.3390/metabo15040220 · Cited by 88 · see citing works
Oktaviono, Y. H., Lamara, A. D., Saputra, P. B. T., Arnindita, J. N., Pasahari, D., Saputra, M. E., & Suasti, N. M. A. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.8893 · Cited by 87 · see citing works
Alterations in gut microbial function following liver transplant
Bajaj, J. S., Kakiyama, G., Cox, I. J., Nittono, H., Takei, H., White, M. B., Fagan, A., Gavis, E. A., Heuman, D. M., Gilles, H., et al. (2018) · Liver Transplantation · doi:10.1002/lt.25046 · Cited by 79 · see citing works
Gut Microbiome: Profound Implications for Diet and Disease
Hills, R. D., Pontefract, B., Mishcon, H. R., Black, C. A., Sutton, S. C., & Theberge, C. R. (2022) · Kompass Nutrition & Dietetics · doi:10.1159/000523712 · Cited by 79 · see citing works
Homeostasis in the Gut Microbiota in Chronic Kidney Disease
Bhargava, S., Merckelbach, E., Noels, H., Vohra, A., & Jankowski, J. (2022) · Toxins · doi:10.3390/toxins14100648 · Cited by 76 · see citing works
Rajakovich, L. J., Fu, B., Bollenbach, M., & Balskus, E. P. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101498118 · Cited by 74 · see citing works
Amelioration of TMAO through probiotics and its potential role in atherosclerosis
Din, A. U., Hassan, A., Zhu, Y. S., Yin, T., Gregersen, H. N., & Wang, G. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10142-4 · Cited by 75 · see citing works
Pan, T., Pei, Z., Fang, Z., Wang, H., Zhu, J., Zhang, H., Zhao, J., Chen, W., & Lu, W. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1154346 · Cited by 72 · see citing works
Chromatin dynamics and histone modifications in intestinal microbiota-host crosstalk
Fellows, R., & Varga‐Weisz, P. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.12.005 · Cited by 71 · see citing works
Ilyas, A., Wijayasinghe, Y. S., Khan, I., Samaloty, N. M. E., Adnan, M., Dar, T. A., Poddar, N. K., Singh, L. R., Sharma, H., & Khan, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.964624 · Cited by 71 · see citing works
Chen, P., Li, S., Koh, Y., Wu, J.-C., Yang, M., Ho, C., & Pan, M. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03092 · Cited by 69 · see citing works
Noecker, C. A., Chiu, H.-C., McNally, C. P., & Borenstein, E. (2019) · mSystems · doi:10.1128/msystems.00579-19 · Cited by 66 · see citing works
Pancreatic and mucosal enzymes in choline phospholipid digestion
Nilsson, Å., & Duan, R. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00320.2018 · Cited by 68 · see citing works
The gut–brain axis underlying hepatic encephalopathy in liver cirrhosis
He, X., Hu, M., Xu, Y., Xia, F., Tan, Y., Wang, Y., Xiang, H., Wu, H., Ji, T., Xu, Q., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03405-9 · Cited by 66 · see citing works
Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?
Jiang, L., & Schnabl, B. (2020) · Physiology · doi:10.1152/physiol.00005.2020 · Cited by 64 · see citing works
Wu, Q., Wu, S., Yang, C., Zhang, Z., Mao, G., Li, S., Yang, Y., Zhang, X., Wu, M., & Tong, H. (2021) · Food & Function · doi:10.1039/d0fo03329d · Cited by 66 · see citing works
Delgado, J., Ansorena, D., HECKE, T. V., Astiasarán, I., SMET, S. D., & Estévez, M. (2020) · Meat Science · doi:10.1016/j.meatsci.2020.108278 · Cited by 65 · see citing works
Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
Jing, L., Zhang, H., Xiang, Q., Shen, L., Guo, X., Zhai, C., & Hu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.864600 · Cited by 66 · see citing works
Bacteria and Methanogens in the Human Microbiome: a Review of Syntrophic Interactions
Djemai, K., Drancourt, M., & Alou, M. T. (2021) · Microbial Ecology · doi:10.1007/s00248-021-01796-7 · Cited by 63 · see citing works
Macpherson, M. E., Hov, J. R., Ueland, T., Dahl, T. B., Kummen, M., Otterdal, K., Holm, K., Berge, R. K., Mollnes, T. E., Trøseid, M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574500 · Cited by 60 · see citing works
Day-Walsh, P. E., Shehata, E., Saha, S., Savva, G. M., Nemeckova, B., Speranza, J., Kellingray, L., Narbad, A., & Kroon, P. A. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02572-6 · Cited by 61 · see citing works
Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
Xie, B., Zu, X., Wang, Z., Xu, X., Liu, G., & Liu, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.990476 · Cited by 62 · see citing works
Occurrence and expression of genes encoding methyl-compound production in rumen bacteria
Kelly, W. J., Leahy, S. C., Kamke, J., Soni, P., Koike, S., Mackie, R. I., Seshadri, R., Cook, G. M., Morales, S. E., Greening, C., et al. (2019) · Animal Microbiome · doi:10.1186/s42523-019-0016-0 · Cited by 61 · see citing works
Mei, Z., Chen, G., Wang, Z., Usyk, M., Yu, B., Baeza, Y. V., Humphrey, G. C., Benítez, R. A. S., Li, J., Williams-Nguyen, J. S., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab001 · Cited by 60 · see citing works
Mo, X., Cheng, R., Shen, L., Sun, Y., Wang, P., Jiang, G., Lin, W. Y., Li, X., Peng, X., Liao, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.015 · Cited by 61 · see citing works
Via, A. D., Gargari, G., Taverniti, V., Rondini, G., Velardi, I., Gambaro, V., Visconti, G. L., Vitis, V. D., Gardana, C., Ragg, E. M., et al. (2019) · Nutrients · doi:10.3390/nu12010062 · Cited by 62 · see citing works
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 60 · see citing works
Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity
Bu, J., & Wang, Z. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/6458094 · Cited by 59 · see citing works
Alexander, J. L., Mullish, B. H., Danckert, N. P., Liu, Z., Olbei, M. L., Saifuddin, A., Torkizadeh, M., Ibraheim, H., Blanco, J. M., Roberts, L. A., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2022.104430 · Cited by 57 · see citing works
Zhu, J., & He, L. (2024) · Microorganisms · doi:10.3390/microorganisms12040642 · Cited by 58 · see citing works
- Authors
- Rath, S., Heidrich, B., Pieper, D. H., & Vital, M.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Vital, Marius
- Venue
- Microbiome
- Published
- 2017-05-15
- Volume
- 5
- Issue
- 1
- Pages
- 54-54
- ISSN
- 2049-2618 (ISSN-L)
- PMC
- PMC5433236
- OpenAlex
- W2612729422
- Cited by
- 515
- References
- 32
- Citations by year
- 2026: 51 · 2025: 65 · 2024: 75 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 48 · 2019: 45 · 2018: 31 · 2017: 8
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Microbiome (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HZI (Helmholtz Centre for Infection Research) (submittedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Physical Sciences › Environmental Science › Ecology › Microbial Community Ecology and Physiology
- Keywords
- trimethylamine, gut microbiota, CutC, quaternary amines, choline, L-carnitine, Clostridium XIVa, Escherichia coli, atherosclerosis, cardiovascular disease, metagenomics, Human Microbiome Project
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Bacterial Proteins, Feces, Humans, Methylamines, Phylogeny, Sequence Analysis, DNA, Biosynthetic Pathways, Metagenomics, Multilocus Sequence Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review